Literature DB >> 26598524

The Retinoblastoma Tumor Suppressor Protein (pRb)/E2 Promoter Binding Factor 1 (E2F1) Pathway as a Novel Mediator of TGFβ-induced Autophagy.

Juliana Korah1, Lucie Canaff1, Jean-Jacques Lebrun2.   

Abstract

TGFβ is a multifunctional cytokine that regulates cell proliferation, cell immortalization, and cell death, acting as a key homeostatic mediator in various cell types and tissues. Autophagy is a programmed mechanism that plays a pivotal role in controlling cell fate and, consequently, many physiological and pathological processes, including carcinogenesis. Although autophagy is often considered a pro-survival mechanism that renders cells viable in stressful conditions and thus might promote tumor growth, emerging evidence suggests that autophagy is also a tumor suppressor pathway. The relationship between TGFβ signaling and autophagy is context-dependent and remains unclear. TGFβ-mediated activation of autophagy has recently been suggested to contribute to the growth inhibitory effect of TGFβ in hepatocarcinoma cells. In the present study, we define a novel process of TGFβ-mediated autophagy in cancer cell lines of various origins. We found that autophagosome initiation and maturation by TGFβ is dependent on the retinoblastoma tumor suppressor protein/E2 promoter binding factor (pRb/E2F1) pathway, which we have previously established as a critical signaling axis leading to various TGFβ tumor suppressive effects. We further determined that TGFβ induces pRb/E2F1-dependent transcriptional activation of several autophagy-related genes. Together, our findings reveal that TGFβ induces autophagy through the pRb/E2F1 pathway and transcriptional activation of autophagy-related genes and further highlight the central relevance of the pRb/E2F1 pathway downstream of TGFβ signaling in tumor suppression.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  autophagy; cancer; hepatocellular carcinoma; retinoblastoma protein (pRb, RB); transforming growth factor beta (TGF-β); tumor suppressor gene

Mesh:

Substances:

Year:  2015        PMID: 26598524      PMCID: PMC4732193          DOI: 10.1074/jbc.M115.678557

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

Review 1.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

2.  Use of chromatin immunoprecipitation to clone novel E2F target promoters.

Authors:  A S Weinmann; S M Bartley; T Zhang; M Q Zhang; P J Farnham
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

3.  Smad3 potentiates transforming growth factor beta (TGFbeta )-induced apoptosis and expression of the BH3-only protein Bim in WEHI 231 B lymphocytes.

Authors:  Gary M Wildey; Supriya Patil; Philip H Howe
Journal:  J Biol Chem       Date:  2003-03-13       Impact factor: 5.157

4.  E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression.

Authors:  Chang-Rung Chen; Yibin Kang; Peter M Siegel; Joan Massagué
Journal:  Cell       Date:  2002-07-12       Impact factor: 41.582

Review 5.  Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer.

Authors:  Peter M Siegel; Joan Massagué
Journal:  Nat Rev Cancer       Date:  2003-11       Impact factor: 60.716

6.  Transforming growth factor-beta 1 induces apoptosis independently of p53 and selectively reduces expression of Bcl-2 in multipotent hematopoietic cells.

Authors:  J M Francis; C M Heyworth; E Spooncer; A Pierce; T M Dexter; A D Whetton
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

7.  TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase.

Authors:  Chuan-Wei Jang; Chun-Han Chen; Chun-Chieh Chen; Jia-yun Chen; Yi-Hsien Su; Ruey-Hwa Chen
Journal:  Nat Cell Biol       Date:  2002-01       Impact factor: 28.824

8.  The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.

Authors:  S Itoh; J Ericsson; J Nishikawa; C H Heldin; P ten Dijke
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

9.  Induction of autophagy and inhibition of tumorigenesis by beclin 1.

Authors:  X H Liang; S Jackson; M Seaman; K Brown; B Kempkes; H Hibshoosh; B Levine
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

10.  Activin/TGF-beta induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP.

Authors:  Hector Valderrama-Carvajal; Eftihia Cocolakis; Annie Lacerte; Eun-Hye Lee; Gerald Krystal; Suhad Ali; Jean-Jacques Lebrun
Journal:  Nat Cell Biol       Date:  2002-12       Impact factor: 28.824

View more
  13 in total

Review 1.  Defining the momiome: Promiscuous information transfer by mobile mitochondria and the mitochondrial genome.

Authors:  Bhupendra Singh; Josephine S Modica-Napolitano; Keshav K Singh
Journal:  Semin Cancer Biol       Date:  2017-05-11       Impact factor: 15.707

Review 2.  BANCR: a cancer-related long non-coding RNA.

Authors:  Xin Yu; Heyi Zheng; Matthew Tv Chan; William Ka Kei Wu
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

3.  Autophagy acts through TRAF3 and RELB to regulate gene expression via antagonism of SMAD proteins.

Authors:  Alice C Newman; Alain J Kemp; Yvette Drabsch; Christian Behrends; Simon Wilkinson
Journal:  Nat Commun       Date:  2017-11-16       Impact factor: 14.919

4.  Genomic structure, expression pattern, and functional characterization of transcription factor E2F-2 from black tiger shrimp (Penaeus monodon).

Authors:  Bobo Xie; Pengfei Wang; Chao Zhao; Lihua Qiu
Journal:  PLoS One       Date:  2017-05-30       Impact factor: 3.240

Review 5.  Autophagy and epithelial-mesenchymal transition: an intricate interplay in cancer.

Authors:  Mila Gugnoni; Valentina Sancisi; Gloria Manzotti; Greta Gandolfi; Alessia Ciarrocchi
Journal:  Cell Death Dis       Date:  2016-12-08       Impact factor: 8.469

6.  Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo.

Authors:  Zijun Zhou; Hua Jiang; Jiejun Xia; Jing Zhang
Journal:  Int J Oncol       Date:  2020-06-22       Impact factor: 5.650

7.  Transforming growth factor β1 suppresses proinflammatory gene program independent of its regulation on vascular smooth muscle differentiation and autophagy.

Authors:  Ping Gao; Wen Wu; Jiemei Ye; Yao Wei Lu; Alejandro Pablo Adam; Harold A Singer; Xiaochun Long
Journal:  Cell Signal       Date:  2018-07-11       Impact factor: 4.315

8.  An integrative multi-omics approach uncovers the regulatory role of CDK7 and CDK4 in autophagy activation induced by silica nanoparticles.

Authors:  Chen Ruan; Chenwei Wang; Xuanqing Gong; Ying Zhang; Wankun Deng; Jiaqi Zhou; Dengtong Huang; Zining Wang; Qiong Zhang; Anyuan Guo; Jiahong Lu; Jinhao Gao; Di Peng; Yu Xue
Journal:  Autophagy       Date:  2020-05-23       Impact factor: 16.016

9.  Transforming Growth Factor-beta Regulation of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular Migration.

Authors:  Ibrahim Y Hachim; Manuel Villatoro; Lucie Canaff; Mahmood Y Hachim; Julien Boudreault; Halema Haiub; Suhad Ali; Jean-Jacques Lebrun
Journal:  Sci Rep       Date:  2017-11-03       Impact factor: 4.379

10.  A Novel E2F1-EP300-VMP1 Pathway Mediates Gemcitabine-Induced Autophagy in Pancreatic Cancer Cells Carrying Oncogenic KRAS.

Authors:  Alejandro Ropolo; Cintia Catrinacio; Felipe Javier Renna; Veronica Boggio; Tamara Orquera; Claudio D Gonzalez; Maria I Vaccaro
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-23       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.